RE:RE:Softening up for a stink bid? Much appreciated John.
Finding it difficult to move on from that ‘mIstake’ myself. Not sure whether it’s that each member of our learned MSAB individually failed to notice that they’d neglected to specify the manner of dosing or that the Chief Clinical Investigator - lacking any such guidance - then failed to refer back to them to specifically obtain it or whether it’s that for the incorrect dosing we are advised by Management to blame members of the Company itself who at the same time we were told were being kept at a long arms` length from the Trial process or whether it is - peculiarly and in this one instance - ‘The Silence of the Health Canada’ or whether it’s that the Company has done sweet FA to enlighten us on any of this.